EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Iterum Therapeutics PLC (ITRM) EBITDA Margin data is not available.
| Income Statement Financials | |
$0.39M |
|
$-8.98M |
|
$0.02M |
|
$0.37M |
|
$8.12M |
|
$-7.73M |
|
$-1.12M |
|
$-8.85M |
|
$-8.85M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-7.73M |
|
$-7.38M |
|
45.80M |
|
45.80M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$13.73M |
|
$0.02M |
|
$18.78M |
|
$32.50M |
|
$6.43M |
|
$21.21M |
|
$33.45M |
|
$39.88M |
|
$-7.38M |
|
$-26.09M |
|
$-7.38M |
|
48.99M |
|
| Cash Flow Statement Financials | |
$-15.26M |
|
$-0.01M |
|
$2.16M |
|
$24.16M |
|
$11.03M |
|
$-13.13M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
1.53 |
|
-2.91 |
|
94.87% |
|
-1982.31% |
|
-1982.31% |
|
|
EBITDA Margin |
-- |
-2268.46% |
|
-2302.31% |
|
$-15.27M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
0.87 |
|
103.38 |
|
121.65% |
|
34.41% |
|
-27.63% |
|
-64.91% |
|
$-0.15 |
|
$-0.33 |
|
$-0.33 |
|